about   CII home   shop   checkout
 
Save 10%

Additional Training


Immuno-Oncology: An Introductory Overview, Organized by Healthcare Education Services - Instructors



About our Course Instructors:

Dr. John Curnow

John Curnow is a senior non-clinical lecturer in the School of Immunity & Infection in the College of Medical and Dental Sciences. John has published over 50 research papers in scientific journals in the field of translational human immunology, in particular ocular immunology. He has received grants from Fight for Sight, the Medical Research Council and the MS Society. In addition to his research he is committed to research-focused teaching and at both an undergraduate and postgraduate level.

Geoffrey Gibney, M.D.

Geoffrey T. Gibney, MD, is a co-leader of the Melanoma Disease Group at the Lombardi Comprehensive Cancer Center and MedStar Cancer Network, and a member of the Developmental Therapeutics (Phase I) program. He is well known for treating patients with advanced non-melanoma skin cancers (basal cell carcinoma, squamous cell carcinoma and merkel cell carcinoma), renal cell carcinoma and other rare skin cancers. Dr. Gibney is board certified in both internal medicine and medical oncology. He was previously a faculty member in the Department of Cutaneous Oncology at the Moffitt Cancer Center in Tampa.

Dr. Gibney is recognized for his advanced melanoma research. He is currently involved in several clinical trials focused on developing novel immunotherapy and targeted therapy strategies. Past clinical research has included the study of anti-PD-1 therapy to prevent recurrences of resected melanoma, combination immunotherapies (such as ipilimumab plus the novel IDO1 inhibitor, epacadostat) to enhance the clinical benefit in advanced melanoma patients and combination BRAF targeted therapy to overcome drug resistance. His current goal is to develop biomarker-driven approaches for personalized therapeutic strategies in patients with advanced malignancies.

Mark Socinski, M.D.
Mark A Socinski, M.D., is the Executive Medical Director of the Florida Hospital Cancer Institute in Orlando, FL and a member of the Institute’s Thoracic Oncology Program. Prior to this appointment in 2016 he was a Professor of Medicine and Thoracic Surgery and the Director of the Lung Cancer Section of the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine. Prior to this Dr Socinski was a Professor of Medicine and member of the Multidisciplinary Thoracic Oncology Program at the Lineberger Comprehensive Cancer Center on the campus of the University of North Carolina at Chapel Hill. Dr. Socinski received his medical degree from the University of Vermont College of Medicine and completed his training in Internal Medicine at Beth Israel Hospital, Harvard Medical School in Boston, MA. He subsequently completed his fellowship in Medical Oncology at the Dana-Farber Cancer Institute in Boston, MA.

Along with his colleagues, he was instrumental in the initiation of the Multidisciplinary Thoracic Oncology Program at UNC in 1995. Dr. Socinski is a recognized national and international expert in the field of Thoracic Oncology. His primary interest involves clinical trials research in all aspects of thoracic oncology. Dr. Socinski is an active member of the Respiratory Core Committee of ALLIANCE as well as the American Colleges Chest Physicians and the American Society of Clinical Oncology. He has authored or co-authored many articles, abstracts, book chapters, and monographs predominantly focused on issues in thoracic oncology

Download Conference & Course Catalog

CHI Catalog Cover